Indefinite Delivery Contract SPE2DX15D5028

The Indefinite Delivery Contract (IDC) SPE2DX15D5028 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999.00 single-award IDC, with a period of performance through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This IDC enables efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism. Additionally, Amerisourcebergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Amerisourcebergen's parent company, Cencora, Inc., also maintains a significant $999,999,999.00 IDC with the DLA Troop Support Medical, which runs through December 31, 2025. This single-award IDC serves as a primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract awards to both Amerisourcebergen and Cencora, Inc. demonstrate their critical role as key vendors for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs healthcare systems.